We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Computer Program Refines Cancer Diagnosis

By Biotechdaily staff writers
Posted on 19 Feb 2004
Researchers have developed a computer program that analyzes data from mass spectrometer examination of blood samples and can differentiate between blood samples from healthy individuals and from those with ovarian or prostate cancers.

Investigators at Dartmouth College (Hanover, NH, USA) published the details of this new algorithm, which they called Q5, in the December 2003 issue of the Journal of Computational Biology. More...
The algorithm employs principal components analysis (PCA) followed by linear discriminant analysis (LDA) on whole spectrum surface-enhanced laser desorption/ionization time of flight (SELDI-TOF) mass spectrometry (MS) data.

Applying the algorithm to data obtained by mass spectrometer examination of blood samples, the investigators were able to identify patients with ovarian cancer with virtually 100% accuracy and those with prostate cancer with approximately 95% accuracy.

"Our algorithm, named Q5, works on the assumption that the molecular composition of the blood changes between healthy and disease states,” explained senior author Dr. Bruce Donald, professor of computer science at Dartmouth College. "The goal of our work is to develop minimally invasive diagnostic methods with high predictive accuracy, and this is a promising first step.”



Related Links:
Dartmouth College

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.